United Therapeutics (UTHR) Tops Estimates, Posts Q3 $0.66
More News related to UTHR
- United Therapeutics (UTHR) Tops Estimates, Posts Q3 $0.66
- United Therapeutics Corporation Reports Third Quarter 2009 Financial Results
- Trading Radar for 10/29: Exxon (XOM), Motorola (MOT), Waste Management (WM) Report
- United Therapeutics (UTHR) November volatility at 56, January at 43 into EPS
- United Therapeutics Corporation to Announce Third Quarter 2009 Financial Results Before Market Open on Thursday, October 29, 2009
More News related to Earnings
- Maxim Group Initiates Coverage on Golden Green Enterprises (CHOP) with a Buy
- Hilliard Lyons Initiates Coveage on Approach Resources (AREX) with a Buy
- Wells Fargo Transfers Coverage on Intuitive Surgical (ISRG) to a Market Perform; Raises Valuation Range
- Wedbush Initiates Coverage on Coinstar (CSTR) with an Outperform
- Thomas Weisel Starts FARO Tech. (FARO) at Overweight, $24 Price Target
United Therapeutics (NASDAQ: UTHR) reports Q3 EPS of $0.66, versus the analyst estimate of $0.30. Revenue for the quarter was $97.22 million, which compares to the estimate of $90.20 million.
Related Categories
EarningsStocks Mentioned
+0.30Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
